Community Health Begins with Source Water
EQO is the only company capable of offering eRNA diagnostic solutions through the use of an automated collection system. EQO's automated samplers are installed onsite to collect and preserve biological material that are then shipped to EQO for analysis and replaced with new samplers.
EQO scientist extract, preserve, catalogue, and analyze genetic information to determine the stage of infestation. EQO then provides the customer with actionable information needed to efficiently treat a population of zebra mussels, whether it's a newly established population or an older infestation.
EQO automated collection system can be semi-permanently installed onsite to monitor population activity. Effective management of invasive species infestation requires population activity information. This can only be determined through consistent monitoring, allowing for treatment optimization and quality control.
EQO has developed a biotherapeutic infestation treatment funded by the National Science Foundation and the U.S. Bureau of Reclamation. The product will be available to the public in late 2020. The product has limited to no off-target effects with high efficiency. For more information, please contact us.
EQO offers full spectrum invasive species control for prevention, mitigation, monitoring, and treatment through EQO Rx and EQO Dx.
EQO Dx: Invasive population analytics powered by RNA.
EQO is the only company capable of offering eRNA solutions, providing the necessary metrics for scalable prevention and mitigation.
EQO offers scalable automated collection and preservation of biological samples for targeted and highly sensitive eDNA and eRNA analytics.
EQO Rx: The prescription for restoration.
Environmentally friendly, biotherapeutic, eradication solution built with the support of the National Science Foundation and Bureau of Reclamation for the control of invasive mussels.
Biomolecule packaged in an attenuated, not live, microalgae delivery vector.
Based on previous research in the field of oncology which has seen clinical efficacy for the treatment of cancer without harm to non-tumor cells.